Mebiopharm Co., Ltd   Report issue

For profit Phase 2
Founded: Tokyo Japan (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2006
NCT00355888
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

fluorouracil (efudex) (1 trial)

leucovorin (1 trial)

mbp-426 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Esophageal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3